Effect of Statin Treatment on Modifying Plaque Composition A Double-Blind, Randomized Study

Journal of the American College of Cardiology

Volumn 67, Issue 15, 2016, Pages 1772-1783

  Park, Seung Jung ^a   Kang, Soo Jin ^a   Ahn, Jung Min ^a   Chang, Mineok ^a   Yun, Sung Cheol ^a   Roh, Jae Hyung ^a   Lee, Pil Hyung ^a   Park, Hyun Woo ^a   Yoon, Sung Han ^a   Park, Duk Woo ^a   Lee, Seung Whan ^a   Kim, Young Hak ^a   Lee, Cheol Whan ^a   Mintz, Gary S ^b   Han, Ki Hoon ^a   Park, Seong Wook ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

atherosclerosis; hydroxymethylglutaryl CoA reductase inhibitors; intravascular ultrasound

Indexed keywords

C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCORE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HISTOLOGY; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NECROTIC CORE VOLUME; OPTICAL COHERENCE TOMOGRAPHY; PLAQUE VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TOTAL ATHEROMA VOLUME; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG EFFECTS; DRUG MONITORING; ECHOGRAPHY; INTERVENTIONAL ULTRASONOGRAPHY; MIDDLE AGED; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; PROCEDURES; PROGNOSIS; TREATMENT OUTCOME;

CORONARY ARTERY DISEASE; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; ROSUVASTATIN CALCIUM; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84963664681     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.02.014     Document Type: Article

References (23)

1. F.M. Sacks, M.A. Pfeffer, L.A. Moye, et al. for the Cholesterol and Recurrent Events Trial Investigators The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels N Engl J Med 335 1996 1001 1009
2. P.M. Ridker, E. Danielson, F.A. Fonseca, et al. for the JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
3. P. Tung, S.D. Wiviott, C.P. Cannon, and et al. Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of pravastatin (40 mg) or atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study) Am J Cardiol 103 2009 1056 1060
4. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, et al. for the REVERSAL Investigators Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial JAMA 291 2004 1071 1080
5. S.E. Nissen, S.J. Nicholls, I. Sipahi, et al. for the ASTEROID Investigators Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial JAMA 295 2006 1556 1565
6. S.J. Nicholls, C.M. Ballantyne, P.J. Barter, and et al. Effect of two intensive statin regimens on progression of coronary disease N Engl J Med 365 2011 2078 2087
7. S.E. Nissen, E.M. Tuzcu, P. Schoenhagen, et al. for the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease N Engl J Med 352 2005 29 38
8. T. Hiro, T. Kimura, T. Morimoto, et al. for the JAPAN-ACS Investigators Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study) J Am Coll Cardiol 54 2009 293 302
9. S.C. Smith Jr., and S.M. Grundy 2013 ACC/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol J Am Coll Cardiol 64 2014 601 612
10. G.W. Stone, A. Maehara, A.J. Lansky, et al. for the PROSPECT Investigators A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
11. T.J. Ryan, D.P. Faxon, R.M. Gunnar, and et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty) J Am Coll Cardiol 22 1993 2033 2054
12. G.S. Mintz, S.E. Nissen, W.D. Anderson, and et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 37 2001 1478 1492
13. H.M. García-García, G.S. Mintz, A. Lerman, and et al. Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting EuroIntervention 5 2009 177 189
14. T. Kubo, A. Maehara, G.S. Mintz, and et al. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization J Am Coll Cardiol 55 2010 1590 1597
15. A. Maehara, E. Cristea, G.S. Mintz, and et al. Definitions and methodology for the grayscale and radiofrequency intravascular ultrasound and coronary angiographic analyses J Am Coll Cardiol Img 5 3 Suppl 2012 S1 S9
16. K.H. Yun, G.S. Mintz, N. Farhat, and et al. Relation between angiographic lesion severity, vulnerable plaque morphology and future adverse cardiac events (from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree Study) Am J Cardiol 110 2012 471 477
17. F. Prati, E. Regar, G.S. Mintz, et al. for the Expert's OCT Review Document Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis Eur Heart J 31 2010 401 415
18. I.K. Jang, G.J. Tearney, B. MacNeill, and et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography Circulation 111 2005 1551 1555
19. G.J. Tearney, E. Regar, T. Akasaka, et al. for the International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT) Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation J Am Coll Cardiol 59 2012 1058 1072
20. T. Kume, T. Akasaka, T. Kawamoto, and et al. Assessment of coronary arterial thrombus by Optical Coherence Tomography Am J Cardiol 97 2006 1713 1717
21. K. Komukai, T. Kubo, H. Kitabata, and et al. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT Study J Am Coll Cardiol 64 2014 2207 2217
22. S. Okazaki, T. Yokoyama, K. Miyauchi, and et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study Circulation 110 2004 1061 1068
23. C.W. Lee, S.J. Kang, J.M. Ahn, and et al. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial) Am J Cardiol 109 2012 1700 1704